var data={"title":"Guaifenesin and dextromethorphan: Pediatric drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Guaifenesin and dextromethorphan: Pediatric drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/6288?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=guaifenesin-and-dextromethorphan-drug-information\" class=\"drug drug_general\">see &quot;Guaifenesin and dextromethorphan: Drug information&quot;</a> and <a href=\"topic.htm?path=guaifenesin-and-dextromethorphan-patient-drug-information\" class=\"drug drug_patient\">see &quot;Guaifenesin and dextromethorphan: Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F177719\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Cheracol D [OTC];</li>\n      <li>Cheracol Plus [OTC];</li>\n      <li>Coricidin HBP Chest Congestion and Cough [OTC];</li>\n      <li>Delsym Cough + Chest Congestion DM [OTC];</li>\n      <li>Diabetic Siltussin-DM DAS-Na Maximum Strength [OTC];</li>\n      <li>Diabetic Siltussin-DM DAS-Na [OTC];</li>\n      <li>Diabetic Tussin DM Maximum Strength [OTC];</li>\n      <li>Diabetic Tussin DM [OTC];</li>\n      <li>Double Tussin DM [OTC];</li>\n      <li>Fenesin DM IR [OTC];</li>\n      <li>GoodSense Mucus Relief DM [OTC];</li>\n      <li>Guaicon DMS [OTC];</li>\n      <li>Iophen DM-NR [OTC] [DSC];</li>\n      <li>Kolephrin GG/DM [OTC];</li>\n      <li>Mucinex DM Maximum Strength [OTC];</li>\n      <li>Mucinex DM [OTC];</li>\n      <li>Mucinex Fast-Max DM Max [OTC];</li>\n      <li>Mucinex Kid&rsquo;s Cough Mini-Melts [OTC];</li>\n      <li>Mucinex Kid&rsquo;s Cough [OTC];</li>\n      <li>Q-Tussin DM [OTC];</li>\n      <li>Refenesen DM [OTC];</li>\n      <li>Robafen DM [OTC];</li>\n      <li>Robitussin Maximum Strength Cough + Congestion DM [OTC];</li>\n      <li>Robitussin Peak Cold Cough + Chest Congestion DM [OTC];</li>\n      <li>Robitussin Peak Cold Maximum Strength Cough + Chest Congestion DM [OTC];</li>\n      <li>Robitussin Peak Cold Sugar-Free Cough + Chest Congestion DM [OTC];</li>\n      <li>Safe Tussin DM [OTC];</li>\n      <li>Scot-Tussin Senior [OTC];</li>\n      <li>Silexin [OTC];</li>\n      <li>Siltussin DM DAS [OTC];</li>\n      <li>Siltussin DM [OTC];</li>\n      <li>Triaminic Cough &amp; Congestion [OTC];</li>\n      <li>Vicks 44E [OTC];</li>\n      <li>Vicks DayQuil Mucus Control DM [OTC];</li>\n      <li>Vicks Nature Fusion Cough &amp; Chest Congestion [OTC] [DSC];</li>\n      <li>Vicks Pediatric Formula 44E [OTC];</li>\n      <li>Zyncof [OTC]</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F177720\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Balminil DM E;</li>\n      <li>Benylin DM-E</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1059117\" class=\"list_set htclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Therapeutic Category</span>\n    <ul>\n      <li>\n        <span class=\"list-set-name\">Antitussive</span>;</li>\n      <li>\n        <span class=\"list-set-name\">Expectorant</span></li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1059112\" class=\"block dos drugH1Div\"><span class=\"drugH1\">Dosing: Usual</span><p>(For additional information <a href=\"topic.htm?path=guaifenesin-and-dextromethorphan-drug-information\" class=\"drug drug_general\">see &quot;Guaifenesin and dextromethorphan: Drug information&quot;</a>)</p>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Note: Multiple concentrations of oral liquid formulations (liquid, solution, and syrup) exist; close attention must be paid to the concentration when ordering or administering. </b></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Pediatric: <b>Note:</b> Refer to product specific labeling for approved pediatric ages.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Cough (antitussive/expectorant):</b> Oral: <b>Note:</b> For all immediate release products (eg, capsules, granules, liquid formulations); do not exceed 6 doses in 24 hours.</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">\n      <i>General dosing:</i> Immediate release products:</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Children 4 to &lt;6 years: Dextromethorphan 2.5 to 5 mg with Guaifenesin 50 to 100 mg every 4 hours as needed</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Children 6 to &lt;12 years: Dextromethorphan 5 to 10 mg with Guaifenesin 100 to 200 mg every 4 hours as needed</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Children &ge;12 years and Adolescents: Dextromethorphan 10 to 20 mg with Guaifenesin 200 to 400 mg every 4 hours as needed</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">\n      <i>Product-specific dosing: </i></p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Capsules, liquid filled: Dextromethorphan 10 mg and Guaifenesin 200 mg per capsule: Children &ge; 12 years and Adolescents:  1 to 2 capsules every 4 hours as needed</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Granules: Dextromethorphan 5 mg and Guaifenesin 100 mg per packet:</p>\n    <p style=\"text-indent:-2em;margin-left:10em;\">Children 4 to &lt;6 years: 1 packet every 4 hours as needed</p>\n    <p style=\"text-indent:-2em;margin-left:10em;\">Children 6 to 11 years: 1 to 2 packets every 4 hours as needed</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Liquid/Solution/Syrup: <b>Note:</b> Multiple concentrations available; close attention must be paid. Refer to product specific labeling for approved pediatric ages.</p>\n    <p style=\"text-indent:-2em;margin-left:10em;\">Dextromethorphan <b>5 mg</b> and Guaifenesin 100 mg per 5 mL:</p>\n    <p style=\"text-indent:-2em;margin-left:12em;\">Children 4 to &lt;6 years:  2.5 to 5 mL every 4 hours as needed</p>\n    <p style=\"text-indent:-2em;margin-left:12em;\">Children 6 to &lt;12 years:  5 to 10 mL every 4 hours as needed</p>\n    <p style=\"text-indent:-2em;margin-left:12em;\">Children &ge;12 years and Adolescents: 10 to 20 mL every 4 hours as needed</p>\n    <p style=\"text-indent:-2em;margin-left:10em;\">Dextromethorphan <b>10 mg</b> and Guaifenesin 100 mg per 5 mL:   </p>\n    <p style=\"text-indent:-2em;margin-left:12em;\">Children 2 to &lt;6 years:  2.5 mL every 4 hours as needed</p>\n    <p style=\"text-indent:-2em;margin-left:12em;\">Children 6 to &lt;12 years:  5 mL every 4 hours as needed</p>\n    <p style=\"text-indent:-2em;margin-left:12em;\">Children &ge;12 years and Adolescents: 10 mL every 4 hours as needed</p>\n    <p style=\"text-indent:-2em;margin-left:10em;\">Dextromethorphan <b>10 mg</b> and Guaifenesin <b>200 mg</b> per 5 mL: Children &ge;12 years and Adolescents: 10 mL every 4 hours as needed</p>\n    <p style=\"text-indent:-2em;margin-left:10em;\">Dextromethorphan 10 mg and Guaifenesin 200 mg <b>per 15 mL</b>:   </p>\n    <p style=\"text-indent:-2em;margin-left:12em;\">Children 6 to &lt;12 years: 15 mL every 4 hours as needed</p>\n    <p style=\"text-indent:-2em;margin-left:12em;\">Children &ge;12 years and Adolescents:  30 mL every 4 hours as needed. </p>\n    <p style=\"text-indent:-2em;margin-left:10em;\">Dextromethorphan <b>20 mg</b> and Guaifenesin <b>400 mg</b> per 5 mL:  Children &ge; 12 years and Adolescents:  5 mL every 4 hours as needed  </p>\n    <p style=\"text-indent:-4em;margin-left:10em;\">Tablet, extended release:</p>\n    <p style=\"text-indent:-4em;margin-left:12em;\">Dextromethorphan 30 mg and Guaifenesin 600 mg per tablet: Children &ge;12 years and Adolescents: 1 to 2 tablets every 12 hours as needed; do not exceed 4 tablets in 24 hours</p>\n    <p style=\"text-indent:-4em;margin-left:12em;\">Dextromethorphan 60 mg and Guaifenesin 1,200 mg per tablet: Children &ge;12 years and Adolescents: 1 tablet every 12 hours as needed; do not exceed 2 tablets in 24 hours</p>\n    <p style=\"text-indent:-4em;margin-left:10em;\">Tablet, immediate release: Dextromethorphan 20 mg and Guaifenesin 400 mg per tablet:</p>\n    <p style=\"text-indent:-4em;margin-left:12em;\">Children 6 to &lt;12 years: <sup>1</sup>/<sub>2</sub>tablet every 4 hours as needed</p>\n    <p style=\"text-indent:-4em;margin-left:12em;\">Children &ge;12 years and Adolescents: 1 tablet  every 4 hours as needed</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Adult: <b>General dosing guidelines:</b> Oral: Guaifenesin 200 to 400 mg and dextromethorphan 10 to 20 mg every 4 hours (maximum dose: Guaifenesin 2,400 mg and dextromethorphan 120 mg per day)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F177707\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling. [DSC] = Discontinued product.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Caplet, oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Fenesin DM IR: Guaifenesin 400 mg and dextromethorphan hydrobromide 15 mg [DSC]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Fenesin DM IR: Guaifenesin 400 mg and dextromethorphan hydrobromide 20 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Refenesen DM: Guaifenesin 400 mg and dextromethorphan hydrobromide 20 mg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Capsule, oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Coricidin HBP Chest Congestion and Cough: Guaifenesin 200 mg and dextromethorphan hydrobromide 10 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Robitussin Maximum Strength Cough + Congestion DM: Guaifenesin 200 mg and dextromethorphan hydrobromide 10 mg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Granules, oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mucinex Kid&rsquo;s Cough Mini-Melts: Guaifenesin 100 mg and dextromethorphan hydrobromide 5 mg per packet (12s) [contains magnesium 6 mg/pack, phenylalanine 2 mg/packet, sodium 3 mg/packet; orange cr&egrave;me flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Liquid, oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Delsym Cough + Chest Congestion DM: Guaifenesin 100 mg and dextromethorphan hydrobromide 5 mg per 5 mL (180 mL) [contains edetate disodium, proylene glycol, sodium benzoate; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Diabetic Tussin DM: Guaifenesin 100 mg and dextromethorphan hydrobromide 10 mg per 5 mL (120 mL) [dye free, ethanol free, sugar free; contains phenylalanine 8.4 mg/5 mL]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Diabetic Tussin DM Maximum Strength: Guaifenesin 200 mg and dextromethorphan hydrobromide 10 mg per 5 mL (120 mL) [dye free, ethanol free, sugar free; contains phenylalanine 8.4 mg/5 mL]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Double Tussin DM: Guaifenesin 300 mg and dextromethorphan hydrobromide 20 mg per 5 mL (120 mL, 480 mL) [dye free, ethanol free, sugar free]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Iophen DM-NR: Guaifenesin 100 mg and dextromethorphan hydrobromide 10 mg per 5 mL (480 mL [DSC]) [contains propylene glycol, sodium benzoate; raspberry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Kolephrin GG/DM: Guaifenesin 150 mg and dextromethorphan hydrobromide 10 mg per 5 mL (120 mL) [ethanol free; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mucinex Fast-Max DM Max: Guaifenesin 400 mg and dextromethorphan hydrobromide 20 mg per 20 mL (180 mL) [contains propylene glycol, potassium 6 mg/20 mL, sodium 13 mg/20 mL]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mucinex Kid&rsquo;s Cough: Guaifenesin 100 mg and dextromethorphan hydrobromide 5 mg per 5 mL (120 mL) [contains propylene glycol, sodium 3 mg/5 mL; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Robitussin Peak Cold Cough + Chest Congestion DM: Guaifenesin 100 mg and dextromethorphan hydrobromide 10 mg per 5 mL ( 120 mL, 240 mL) [contains menthol, propylene glycol, sodium 3.5 mg/5 mL, sodium benzoate]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Robitussin Peak Cold Sugar-Free Cough + Chest Congestion DM: Guaifenesin 100 mg and dextromethorphan hydrobromide 10 mg per 5 mL (120 mL) [sugar free; contains propylene glycol, sodium 3 mg/5 mL, sodium benzoate]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Robitussin Peak Cold Maximum Strength Cough + Chest Congestion DM: Guaifenesin 200 mg and dextromethorphan hydrobromide 10 mg per 5 mL (120 mL, 240 mL) [contains menthol, propylene glycol, sodium 5 mg/5 mL, sodium benzoate]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Safe Tussin DM: Guaifenesin 100 mg and dextromethorphan hydrobromide 15 mg per 5 mL (120 mL) [contains benzoic acid, phenylalanine 4.2 mg/5 mL, and propylene glycol; orange and mint flavors]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Scot-Tussin Senior: Guaifenesin 200 mg and dextromethorphan hydrobromide 15 mg per 5 mL (120 mL) [ethanol free, sodium free, sugar free]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Vicks 44E: Guaifenesin 200 mg and dextromethorphan hydrobromide 20 mg per 15 mL (120 mL, 235 mL) [contains ethanol, sodium 31 mg/15 mL, sodium benzoate]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Vicks DayQuil Mucus Control DM: Guaifenesin 200 mg and dextromethorphan hydrobromide 10 mg per 15 mL (295 mL) [contains propylene glycol, sodium 25 mg/15 mL, sodium benzoate; citrus blend flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Vicks Nature Fusion Cough &amp; Chest Congestion: Guaifenesin 200 mg and dextromethorphan hydrobromide 20 mg per 30 mL (236 mL [DSC]) [dye free, ethanol free, gluten free; contains propylene glycol, sodium 36 mg/30 mL; honey flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Vicks Pediatric Formula 44E: Guaifenesin 100 mg and dextromethorphan hydrobromide 10 mg per 15 mL (120 mL) [ethanol free; contains sodium 30 mg/15 mL, sodium benzoate; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Generic: Guaifenesin 100 mg and dextromethorphan hydrobromide 10 mg per 5 mL (480 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Syrup, oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Cheracol D: Guaifenesin 100 mg and dextromethorphan hydrobromide 10 mg per 5 mL (120 mL, 180 mL) [contains benzoic acid, ethanol 4.75%]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Cheracol Plus: Guaifenesin 100 mg and dextromethorphan hydrobromide 10 mg per 5 mL (120 mL) [contains benzoic acid, ethanol 4.75%]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Diabetic Siltussin-DM DAS-Na: Guaifenesin 100 mg and dextromethorphan hydrobromide 10 mg per 5 mL (118 mL) [ethanol free, sugar free; contains benzoic acid, phenylalanine 3 mg/5 mL, propylene glycol; strawberry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Diabetic Siltussin-DM DAS-Na Maximum Strength: Guaifenesin 200 mg and dextromethorphan hydrobromide 10 mg per 5 mL (118 mL) [ethanol free, sugar free; contains benzoic acid, phenylalanine 3 mg/5 mL, propylene glycol; strawberry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Guaicon DMS: Guaifenesin 100 mg and dextromethorphan hydrobromide 10 mg per 5 mL (10 mL) [ethanol free, sugar free]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Q-Tussin DM: Guaifenesin 100 mg and dextromethorphan hydrobromide 10 mg per 5 mL (118 mL, 237 mL, 473 mL) [ethanol free, contains sodium benzoate; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Robafen DM: Guaifenesin 100 mg and dextromethorphan hydrobromide 10 mg per 5 mL (120 mL, 240 mL, 480 mL) [cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Silexin: Guaifenesin 100 mg and dextromethorphan hydrobromide 10 mg per 5 mL (45 mL) [ethanol free, sugar free)]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Siltussin DM: Guaifenesin 100 mg and dextromethorphan hydrobromide 10 mg per 5 mL (120 mL, 240 mL, 480 mL) [strawberry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Siltussin DM DAS: Guaifenesin 100 mg and dextromethorphan hydrobromide 10 mg per 5 mL (120 mL) [dye free, ethanol free, sugar free; strawberry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Triaminic Cough &amp; Cold: Guaifenesin 100 mg and dextromethorphan hydrobromide 5 mg per 5 mL (118 mL) [contains propylene glycol, sodium benzoate; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Zyncof: Guaifenesin 400 mg and dextromethorphan hydrobromide 20 mg per 5 mL (120 mL, 480 mL) [dye free, ethanol free, sugar free; contains propylene glycol; grape flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Generic: Guaifenesin 100 mg and dextromethorphan hydrobromide 10 mg per 5 mL (5 mL, 10 mL, 120 mL, 480 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Tablet, oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">GoodSense Mucus Relief DM: Guaifenesin 400 mg and dextromethorphan hydrobromide 20 mg [dye free, gluten free]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Silexin: Guaifenesin 100 mg and dextromethorphan hydrobromide 10 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Generic: Guaifenesin 1000 mg and dextromethorphan hydrobromide 60 mg; guaifenesin 1200 mg and dextromethorphan hydrobromide 60 mg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Tablet, extended release, oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mucinex DM: Guaifenesin 600 mg and dextromethorphan hydrobromide 30 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mucinex DM Maximum Strength: Guaifenesin 1200 mg and dextromethorphan hydrobromide 60 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Generic: Guaifenesin 1200 mg and dextromethorphan hydrobromide 60 mg</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F177694\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Availability (US)</span>\n    <p style=\"text-indent:0em;display:inline\">Yes: Excludes extended release tablet</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1059121\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">Oral: Administer without regard to meals, with a large quantity of fluid to ensure proper effect; do not crush, chew, or break extended release tablets.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F177718\" class=\"block sts drugH1Div\"><span class=\"drugH1\">Storage/Stability</span>\n    <p style=\"text-indent:0em;display:inline\">Store at room temperature.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1059120\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">Temporary relief of cough due to minor throat and bronchial irritation and helps loosen phlegm and thin bronchial secretions. <b>Note:</b> Approved ages and uses for generic products may vary; consult labeling for specific information.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Capsule, liquid-filled: Coricidin HBP, Robitussin Maximum Strength Cough &amp; Congestion DM: FDA approved in ages &ge;12 years and adults</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Granules: Mucinex Cough, Mini-melts for kids: FDA approved in ages 4 years through 12 years</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Liquid:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\tChildren&rsquo;s Delsym Cough + Chest Congestion:  FDA approved in ages &ge; 4 years and adults</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Delsym Cough + Chest Congestion, Robafen:  FDA approved in ages &ge; 12 years and adults</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Iophen DM-NR:  FDA approved in ages &ge; 2 years and adults\t</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Syrup: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Cheracol:  FDA approved in ages &ge; 6 years and adults</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Children&rsquo;s Robitussin Cough &amp; Chest Congestion DM:  FDA approved in ages &ge;6 years and adults</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Robitussin Peak Cold Cough + Chest Congestion DM:  FDA approved in ages &ge;12 years and adults</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Robitussin Maximum Strength Cough + Chest Congestion DM:  FDA approved in ages &ge;12 years and adults</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Triaminic Cough &amp; Congestion:  FDA approved in ages 4 years through 11 years</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Zyncof:  FDA approved in ages &ge;12 years and adults</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Tablet, extended release: Mucinex DM: FDA approved in ages &ge;12 years and adults</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Tablet, immediate release:\tGeneric products:  FDA approved in ages &ge;6 years and adults</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F177743\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues: </span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Benylin may be confused with Benadryl, Ventolin</p>\n        <p style=\"text-indent:-2em;margin-left:4em;\">Mucinex DM may be confused with Mucinex D</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F177741\" class=\"block arm drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:0em;display:inline\">See individual agents.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F177713\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">Concurrent administration with or within 2 weeks of discontinuing an MAO inhibitor</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F177698\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Special populations:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; CYP2D6 poor metabolizers: Dextromethorphan is metabolized by hepatic CYP2D6. Poor metabolizers of CYP2D6 may have exaggerated or prolonged effects of dextromethorphan. Increased risk may be seen with concomitant use of potent CYP2D6 inhibitors; use with caution (Abduljalil 2010; Jurica 2012; Sager 2014; Zhou 2009).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Debilitated patients: Use with caution in patients who are sedated, debilitated or confined to a supine position.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Pediatric: Use with caution in atopic children. Not for OTC use in children &lt;2 years of age.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Benzyl alcohol and derivatives: Some dosage forms may contain sodium benzoate/benzoic acid; benzoic acid (benzoate) is a metabolite of benzyl alcohol; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension, and cardiovascular collapse (AAP [&quot;Inactive&quot; 1997]; CDC 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors 2001); avoid or use dosage forms containing benzyl alcohol derivative with caution in neonates. See manufacturer&rsquo;s labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Phenylalanine: Some products may contain phenylalanine.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Cough: Appropriate use: Underlying cause of cough should be determined prior to prescribing.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Self-medication (OTC use): When used for self medication (OTC), notify health care provider if symptoms do not improve within 7 days, or are accompanied by fever, rash, or persistent headache.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F25881850\" class=\"block add-pediatric-warn-info drugH1Div\"><span class=\"drugH1\">Warnings: Additional Pediatric Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Safety and efficacy for the use of cough and cold products in pediatric patients &lt;4 years of age is limited; the AAP warns against the use of these products for respiratory illnesses in this age group. Serious adverse effects including death have been reported. Many of these products contain multiple active ingredients, increasing the risk of accidental overdose when used with other products. The FDA notes that there are no approved OTC uses for these products in pediatric patients &lt;2 years of age. Health care providers are reminded to ask caregivers about the use of OTC cough and cold products in order to avoid exposure to multiple medications containing the same ingredient.</p>\n    <p style=\"text-indent:0em;margin-top:2em;\">Some dosage forms may contain propylene glycol; in neonates large amounts of propylene glycol delivered orally, intravenously (eg, &gt;3,000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; toxicities have also been reported in children and adults including hyperosmolality, lactic acidosis, seizures and respiratory depression; use caution (AAP, 1997; Shehab, 2009).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F177732\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to individual components.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F177702\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=13345&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:-2em;margin-left:2em;\">Abiraterone Acetate: May increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors). Management: Avoid concurrent use of abiraterone with CYP2D6 substrates that have a narrow therapeutic index whenever possible.  When concurrent use is not avoidable, monitor patients closely for signs/symptoms of toxicity.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Ajmaline: May increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors).<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Antiemetics (5HT3 Antagonists): May enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Antipsychotic Agents: Serotonin Modulators may enhance the adverse/toxic effect of Antipsychotic Agents. Specifically, serotonin modulators may enhance dopamine blockade, possibly increasing the risk for neuroleptic malignant syndrome. Antipsychotic Agents may enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Asunaprevir: May increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors).<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Cobicistat: May increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors).<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">CYP2D6 Inhibitors (Moderate): May decrease the metabolism of CYP2D6 Substrates (High risk with Inhibitors).<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Dapoxetine: May enhance the adverse/toxic effect of Serotonin Modulators.<i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Darunavir: May increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors).<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Imatinib: May increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors).<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Lumefantrine: May increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors).<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Memantine: NMDA Receptor Antagonists may enhance the adverse/toxic effect of Memantine. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Metaxalone: May enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Methylene Blue: May enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome.<i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Methylphenidate: May enhance the adverse/toxic effect of Serotonin Modulators. Specifically, the risk of serotonin syndrome or serotonin toxicity may be increased.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Metoclopramide: Serotonin Modulators may enhance the adverse/toxic effect of Metoclopramide. This may be manifest as symptoms consistent with serotonin syndrome or neuroleptic malignant syndrome. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Monoamine Oxidase Inhibitors: May enhance the serotonergic effect of Dextromethorphan. This may cause serotonin syndrome.<i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Opioid Analgesics: May enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Panobinostat: May increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors). Management: Avoid concurrent use of sensitive CYP2D6 substrates when possible, particularly those substrates with a narrow therapeutic index.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Parecoxib: May increase the serum concentration of Dextromethorphan.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates (High risk with Inhibitors). Peginterferon Alfa-2b may increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors).<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Perhexiline: CYP2D6 Substrates (High risk with Inhibitors) may increase the serum concentration of Perhexiline. Perhexiline may increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors). <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">QuiNIDine: May increase the serum concentration of Dextromethorphan. Management: Avoid concurrent use of these agents when possible, unless the increased psychoactive effects of dextromethorphan are desired.  Since codeine activation is also inhibited by quinidine, codeine is unlikely to be suitable as an alternative antitussive.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">QuiNINE: May increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors).<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Selective Serotonin Reuptake Inhibitors: May enhance the serotonergic effect of Dextromethorphan. Selective Serotonin Reuptake Inhibitors may increase the serum concentration of Dextromethorphan. Management: Avoid the concurrent use of dextromethorphan and SSRIs, particularly fluoxetine and paroxetine, when possible.  The risk for this interaction may persist for several weeks following discontinuation of fluoxetine or paroxetine.<b> Exceptions: </b>FluvoxaMINE.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Serotonin Modulators: May enhance the adverse/toxic effect of other Serotonin Modulators. The development of serotonin syndrome may occur.<b> Exceptions: </b>Nicergoline; Tedizolid.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Tipranavir: May increase the serum concentration of Dextromethorphan. Management: Consider avoiding dextromethorphan in patients taking tipranavir. If combined, monitor closely for increased dextromethorphan effects/toxicities.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">TraMADol: Serotonin Modulators may enhance the adverse/toxic effect of TraMADol. The risk of seizures may be increased. TraMADol may enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome. <i> Risk C: Monitor therapy</i></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F177714\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">See individual agents.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F177697\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Guaifenesin is thought to act as an expectorant by irritating the gastric mucosa and stimulating respiratory tract secretions, thereby increasing respiratory fluid volumes and decreasing phlegm viscosity </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Dextromethorphan is a chemical relative of morphine lacking opioid properties except in overdose; controls cough by depressing the medullary cough center</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F177712\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics (Adult data unless noted)</span>\n    <p style=\"text-indent:0em;display:inline\">See individual agents.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2524625\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Capsules</b> (Robitussin Cough+Chest Cong DM Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">10-200 mg (20): $6.17</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Delsym Cgh/Chest Cong DM Child Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">5-100 mg/5 mL (180 mL): $10.13</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Delsym Cough/Chest Congest DM Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">5-100 mg/5 mL (180 mL): $10.13</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Diabetic Tussin DM Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">100-10 mg/5 mL (118 mL): $4.20</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Diabetic Tussin For Children Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">10-100 mg/5 mL (118 mL): $4.20</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Diabetic Tussin Max St Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">10-200 mg/5 mL (118 mL): $4.46</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Double-Tussin DM Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">20-300 mg/5 mL (240 mL): $7.01</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (G-Tron Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">10-100 mg/5 mL (474 mL): $12.00</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Giltuss Cough &amp; Chest Children Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">10-100 mg/5 mL (118 mL): $7.01</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Giltuss Cough &amp; Chest Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">20-200 mg/10 mL (118 mL): $7.01</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Mucinex Cough Childrens Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">5-100 mg/5 mL (118 mL): $7.76</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Mucinex Fast-Max DM Max Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">20-400 mg/20 mL (180 mL): $10.34</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Pecgen DMX Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">10-187 mg/5 mL (474 mL): $9.30</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Robafen DM Cgh/Chest Congest Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">10-100 mg/5 mL (118 mL): $2.25</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Robitussin Cold Cough+ Chest Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">10-100 mg/5 mL (237 mL): $8.09</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Robitussin Cough+ Chest Max St Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">10-200 mg/5 mL (118 mL): $6.60</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Robitussin Cough+Chest Cong DM Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">5-100 mg/5 mL (118 mL): $5.38</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">20-400 mg/20 mL (118 mL): $6.60</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Robitussin To Go Cgh/Chest DM Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">100-10 mg/5 mL (10 mL): $0.82</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Safe Tussin DM Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">100-10 mg/5 mL (120 mL): $5.26</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Trispec DMX Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">10-187 mg/5 mL (118 mL): $12.77</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">15-125 mg/5 mL (120 mL): $13.16</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Trispec DMX Pediatric Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">10-187 mg/5 mL (59 mL): $12.77</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Pack</b> (Mucinex Cough For Kids Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">5-100 mg (12): $8.14</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Syrup</b> (Dextromethorphan-Guaifenesin Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">10-100 mg/5 mL (237 mL): $4.75</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Syrup</b> (G-Zyncof Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">20-400 mg/5 mL (473 mL): $11.00</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Syrup</b> (Robafen DM Cough Clear Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">100-10 mg/5 mL (118 mL): $2.25</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Syrup</b> (Robitussin Peak Cold DM Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">100-10 mg/5 mL (118 mL): $5.32</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Syrup</b> (Zyncof Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">20-400 mg/5 mL (120 mL): $13.50</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablet, 12-hour</b> (Mucinex DM Maximum Strength Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">60-1200 mg (28): $23.03</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablet, 12-hour</b> (Mucinex DM Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">30-600 mg (20): $12.27</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Dextromethorphan-Guaifenesin Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">20-400 mg (60): $3.60</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Fenesin DM IR Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">20-400 mg (100): $13.20</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Zyncof Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">20-400 mg (60): $28.35</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F177716\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Bre-A-Col (MX);</li>\n      <li>Broncholar (QA);</li>\n      <li>Cheracol D (MX);</li>\n      <li>Debequin C (MX);</li>\n      <li>Dequin (MX);</li>\n      <li>Dexometorfano-Guaifenesina (MX);</li>\n      <li>Diacol (MT);</li>\n      <li>Dimacol (MX);</li>\n      <li>Exiadol (MX);</li>\n      <li>Megal (MX);</li>\n      <li>Robitussin DM (MX);</li>\n      <li>Robitussin-DM (QA);</li>\n      <li>Tukol D (MX);</li>\n      <li>Tussolvina (EC);</li>\n      <li>Xarope 44E (BR)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    American Academy of Pediatrics (AAP). Five things physicians and patients should question. April 4, 2012. Available at http://www.choosingwisely.org/choosing-wisely-five-things-physicians-and-patients-should-question-press-release-april-4-2012/</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    American Academy of Pediatrics Committee on Drugs. &quot;Inactive&quot; ingredients in pharmaceutical products: update (subject review). <i>Pediatrics</i>. 1997;99(2):268-278.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/guaifenesin-and-dextromethorphan-pediatric-drug-information/abstract-text/9024461/pubmed\" target=\"_blank\" id=\"9024461\">9024461</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol - United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291.<a>http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a><span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/guaifenesin-and-dextromethorphan-pediatric-drug-information/abstract-text/6810084 /pubmed\" target=\"_blank\" id=\"6810084 \">6810084 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Cheracol D Cough Formula 4 oz syrup (guaifenesin and dextromethorphan) [prescribing information]. South El Monte CA: Lee Pharmaceuticals; December 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Children's Delsym DM (guaifenesin and dextromethorphan) [prescribing information]. Parsippany, NJ: Reckitt Benckiser; 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Delsym (guaifenesin and dextromethorphan) [prescribing information]. Parsippany, NJ: Reckitt Benckiser; 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Diabetic Maximum Strength Siltussin DM DAS-NA (guaifenesin and dextromethorphan) [prescribing information]. Carmel, NY: Silarx Pharmaceuticals, Inc; June 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Diabetic Siltussin DM DAS-NA (guaifenesin and dextromethorphan) [prescribing information]. Carmel, NY: Silarx Pharmaceuticals, Inc; June 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Diabetic Tussin DM Maximum Strength (guaifenesin and dextromethorphan) [prescribing information]. Amittyville, NY: Health Care Products; September 2012.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Food and Drug Administration (FDA). OTC cough and cold products: not for infants and children under 2 years of age. January 17, 2008. Available at <a href=\"http://www.fda.gov/forconsumers/consumerupdates/ucm048682.htm\" target=\"_blank\">http://www.fda.gov/forconsumers/consumerupdates/ucm048682.htm</a>. Last accessed January 29, 2015. </div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Iophen DM-NR Liquid (guaifenesin and dextromethorphan) [prescribing information]. Huntsaville, AL: Qualitest Pharmaceuticals; October 2009.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Iophen DM-NR solution (guaifenesin and dextromethorphan) [prescribing information]. Huntsaville, AL: Qualitest Pharmaceuticals; March 2015. </div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Mucinex (guaifenesin and dextromethorphan) [prescribing information]. Parsippany, NJ: Reckitt Benckiser; May 2009.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Mucinex Mini-Melts (guaifenesin and dextromethorphan) [prescribing information]. Parsippany, NJ: Reckitt Benckiser; September 2009.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Mucus Relief DM immeduate release (guaifenesin and dextromethorphan) [prescribing information]. Deer Park, NY: Allegiant Health; December 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Q Tussin DM  syrup (guaifenesin and dextromethorphan) [prescribing information]. Huntsaville, AL: Qualitest Pharmaceuticals; January 2013. </div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Robafen DM Cough solution (guaifenesin and dextromethorphan) [prescribing information]. Livonia, MI: Major Pharmaceuticals; October 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. <i>Pediatr Crit Care Med</i>. 2009;10(2):256-259.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/guaifenesin-and-dextromethorphan-pediatric-drug-information/abstract-text/19188870/pubmed\" target=\"_blank\" id=\"19188870\">19188870</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Triaminic Cough &amp; Congestion  (guaifenesin and dextromethorphan) [prescribing information]. Novartis Consumer Health, Inc; 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Zyncof syrup  (guaifenesin and dextromethorphan) [prescribing information]. San Juan, PR: Kramer Novis; December 2012.</div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 13345 Version 116.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F177719\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F177720\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Therapeutic Category\" href=\"#F1059117\" class=\"outlineLink\">Therapeutic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Usual\" href=\"#F1059112\" class=\"outlineLink\">Dosing: Usual</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F177707\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Availability (US)\" href=\"#F177694\" class=\"outlineLink\">Generic Availability (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F1059121\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Storage/Stability\" href=\"#F177718\" class=\"outlineLink\">Storage/Stability</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F1059120\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F177743\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F177741\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F177713\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F177698\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Warnings: Additional Pediatric Considerations\" href=\"#F25881850\" class=\"outlineLink\">Warnings: Additional Pediatric Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F177732\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F177702\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F177714\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F177697\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics (Adult data unless noted)\" href=\"#F177712\" class=\"outlineLink\">Pharmacodynamics/Kinetics (Adult data unless noted)</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F2524625\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F177716\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_PED/13345|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=guaifenesin-and-dextromethorphan-drug-information\" class=\"drug drug_general\">Guaifenesin and dextromethorphan: Drug information</a></li><li><a href=\"topic.htm?path=guaifenesin-and-dextromethorphan-patient-drug-information\" class=\"drug drug_patient\">Guaifenesin and dextromethorphan: Patient drug information</a></li></ul></div></div>","javascript":null}